_________
false
אקס טי אל ביופרמסוטיקלס בע"מ
2
379
X T L BIOPHARMACEUTICALS LTD
Corporation no:
520039470
4313
Israel Securities Authority
Tel Aviv Stock Exchange
C001
(
Public
)
Reported via MAGNA:
03/04/2017
www.isa.gov.il
www.tase.co.il
Reference:
2017-02-036504
Time of broadcast:
18:32
18:25:57
Complementary report for a report sent on date
02/04/2017
whose reference number was
2017-02-035052
Main details added/ completed:
(i) inserting outstanding ADS's and ordinary shares on the front cover and an exchange rate and date on page 67, (ii) removing repetitive language from Note 2 to the financial statements, and (iii) updating the exhibit index.
Report of Periodic or Interim Report
Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
FORM 20-F-2016
Amended_20_F_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
06/03/2017
Address:
HaCharoshet st
5
,
Ra'anana
43656
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E-mail address:
ir@xtlbio.com
Company site:
www.xtlbio.com
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory:
Kntor Ronen
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
abba hillel
12
,
ramat gan
5250606
Telephone:
03-6133371
Facsimile:
03-6133372
E-mail:
rkantor@dtkgc.com
1